We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Global PET-CT Scanner Device Market to Reach USD 3.34 Billion by 2028

By MedImaging International staff writers
Posted on 15 Jun 2021
Print article
Illustration
Illustration
The global PET-CT scanner device market size is expected to register a CAGR of 6.6% from 2021 to 2028 to reach USD 3.34 billion by 2028, driven primarily by the increasing need to overcome the shortfalls of CT and PET in oncology imaging.

The growing prevalence of chronic diseases such as cancer and the outbreak of infectious diseases such as COVID-19, coupled with the rising demand for effective diagnostic systems, are contributing to the overall growth of the market. Moreover, increasing investments for R&D initiatives and rapid technological advancements supporting the development of advanced healthcare devices will foster market growth. These are the latest findings of Polaris Market Research (New York City, NY, USA), a global market research and consulting company.

Based on type, the digital segment is projected to dominate the global PET-CT scanner device market during the forecast period. Such digital scanners come with advanced solid-state sensors, allowing accurate counting of scintillation photons during a scan and it also enhances the quality of images.

In terms of modality, the fixed PET-CT scanner device segment accounted for the largest share in the market on account of higher reliability and enhanced performance. These type of devices offers better patient experience as compared to other devices and also have higher demand in hospitals.

Based on application, the oncology segment contributed the higher revenue share and is expected to add more value to it over the forecast period. PET-CT scanner devices are extensively used for detection & diagnosis of cancer and deciding the treatment required. Based on end-use, the hospital segment continues to hold a dominant share in the global market for the PET-CT scanner devices. An increase in the requirement for diagnostic imaging procedures, advancements in healthcare infrastructure, and innovations in advanced medical devices are contributing to this segment's growth.

Geographically, North America is expected to retain its dominance over the global PET-CT scanner device market as a result of a rising number of traumatic brain injury cases in the region. The availability of established healthcare infrastructure, growing need for early diagnosis of disease, and increasing awareness about preventive healthcare are some of the major factors aiding the market growth in this region. Europe has emerged as the fastest-growing market for PET-CT scanner devices on account of a high rate of installed devices in medical settings and the presence of some of the renowned industry players in the region.

Related Links:
Polaris Market Research

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Table
Powered Ultrasound Table-Flat Top
New
Ceiling-Mounted Digital Radiography System
Radiography 5000 C
New
Compact C-Arm
Arcovis DRF-C S21

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Whole-body maximum-intensity projections over time after [68Ga]Ga-DPI-4452 administration (Photo courtesy of SNMMI)

New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients

Clear cell renal cell cancer (ccRCC) represents 70-80% of renal cell carcinoma cases. While localized disease can be effectively treated with surgery and ablative therapies, one-third of patients either... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more